Welcome
Pharmaceutical & Life Sciences News

Perrigo, Dr. Reddy’s Settle Patent Case Over Psoriasis Drug

Nov. 28, 2018, 6:36 PM

Perrigo and Dr. Reddy’s are asking a federal court in Texas to approve a settlement of a patent infringement lawsuit over the psoriasis drug Sernivo.

The parties said in a Nov. 27 joint motion that they have reached a settlement agreement. They did not disclose the terms of the deal.

Sernivo spray’s annual sales are around $13.9 million, according to the research firm Iqvia. The drug treats mild-to-moderate plaque psoriasis in adults. The potential market for the drug is huge: Nearly 7.5 million people in the U.S. are affected by the condition.

Dr. Reddy’s is still suing Taro Pharmaceutical Industries...

To read the full article log in. To learn more about a subscription click here.